Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept in Atopic Dermatitis
NCT00376129Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Jan 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of alefacept in atopic dermatitis (AD), sponsored by Insel Gruppe. Started Jan 2006; status: completed.
02
Drugs
alefacept
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00376129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376129.